Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm', 'lymphoma']
cd20x3 bite: in those in cr, durable responses and virtually no relapses after 12 cycles fixed-course glofitamab monotherapy! #lymphoma #lymsm #ash22 
Lymphoma Program Director, Colorado Blood Cancer Institute #lymphoma #lymsm #celltherapy #CART #autoimmune #BMT @CBCIDocs @ColoradoBlood ?????? opinions my own